Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.Show others and affiliations
2006 (English)In: Biochim Biophys Acta, ISSN 0006-3002, Vol. 1758, no 1, p. 55-64Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2006. Vol. 1758, no 1, p. 55-64
Keywords [en]
Adenocarcinoma/drug therapy/metabolism, Animals, Chemistry; Pharmaceutical, Cryoelectron Microscopy, Female, Half-Life, Humans, Ionophores/chemistry, Kinetics, Lipids/*chemistry/pharmacokinetics, Liposomes/*chemistry/metabolism, Mice, Mice; Inbred ICR, Research Support; Non-U.S. Gov't, Time Factors, Vincristine/*chemistry/pharmacokinetics/pharmacology
Identifiers
URN: urn:nbn:se:uu:diva-81681PubMedID: 16487476OAI: oai:DiVA.org:uu-81681DiVA, id: diva2:109596
2006-08-302006-08-302011-01-11